Hindustan Bio Sciences (BOM:532041) LT-Debt-to-Total-Asset: 0.74 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532041 Hindustan Bio Sciences Ltd BOM:532041
51 GF Score
Price ₹7.20
GF Value ₹6.11
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Hindustan Bio Sciences LT-Debt-to-Total-Asset?

Hindustan Bio Sciences BOM:532041 +2.27% 51 LT-Debt-to-Total-Asset is 0.74 as of Mar. 2026. GuruFocus rates BOM:532041 with a GF Score™ of 51/100 and a GF Value™ of ₹6.11 (Modestly Overvalued). The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hindustan Bio Sciences's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.74.

Hindustan Bio Sciences's long-term debt to total assets ratio increased from Mar. 2025 (0.73) to Mar. 2026 (0.74). It may suggest that Hindustan Bio Sciences is progressively becoming more dependent on debt to grow their business.

Hindustan Bio Sciences  (BOM:532041) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hindustan Bio Sciences LT-Debt-to-Total-Asset Related Terms

Hindustan Bio Sciences LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Hindustan Bio Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hindustan Bio Sciences LT-Debt-to-Total-Asset Chart

Hindustan Bio Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.34 0.76 0.73 0.74

Hindustan Bio Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.00 0.75 0.00 0.74
BOM:532041
51GF Score
Hindustan Bio Sciences Ltd BOM:532041
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hindustan Bio Sciences LT-Debt-to-Total-Asset Calculation

Hindustan Bio Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=23.495/31.954
=0.74

Hindustan Bio Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=23.495/31.954
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.74 mean?
Hindustan Bio Sciences (BOM:532041) has a LT-Debt-to-Total-Asset of 0.74 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hindustan Bio Sciences and its competitors.
Is Hindustan Bio Sciences' LT-Debt-to-Total-Asset too high?
Hindustan Bio Sciences' current LT-Debt-to-Total-Asset is 0.74. Overall, Hindustan Bio Sciences has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hindustan Bio Sciences' LT-Debt-to-Total-Asset compare to ZTS?
Hindustan Bio Sciences' LT-Debt-to-Total-Asset of 0.74 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Hindustan Bio Sciences and its competitors. Hindustan Bio Sciences's current LT-Debt-to-Total-Asset is 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hindustan Bio Sciences stock overvalued right now?
Based on GuruFocus' analysis, Hindustan Bio Sciences (BOM:532041) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹6.11, compared to a current price of ₹7.20 — trading 17.8% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.74. Hindustan Bio Sciences' overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Hindustan Bio Sciences (BOM:532041), the current LT-Debt-to-Total-Asset is 0.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hindustan Bio Sciences (BOM:532041) Overvalued in 2026?

Based on GuruFocus' analysis, Hindustan Bio Sciences stock appears to be overvalued. The current stock price of ₹7.20 is trading 17.8% above its estimated GF Value™ of ₹6.11. GuruFocus considers Hindustan Bio Sciences to be Modestly Overvalued.

Key valuation signals for BOM:532041:

  • LT-Debt-to-Total-Asset: 0.74
  • GF Value™: ₹6.11 vs. price of ₹7.20 (17.8% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the BOM:532041 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hindustan Bio Sciences Business Description

Address Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an Indian pharmaceutical company, engaged in the manufacturing and sale of pharmaceutical products. The company manufactures and markets drugs and medicines in tablets, capsules, drops, externels, and syrup forms. Geographically, all of its revenue is generated through the export of its products to international markets.
51GF Score

Get the complete analysis for BOM:532041

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.20
Price
₹6.11
GF Value